Board Meeting22 Jun 2026, 05:11 pm

Dr Reddy's Laboratories: Trading Window Closed for Q1 FY27 Results

AI Summary

Dr Reddy's Laboratories Ltd has announced the closure of its trading window from June 24, 2026, to July 24, 2026. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The decision precedes a Board of Directors meeting scheduled for July 22, 2026, where the company will consider its Un-audited Standalone and Consolidated Financial Results for the quarter ending June 30, 2026. The trading window will reopen on July 25, 2026.

Key Highlights

Trading window closed from June 24 to July 24, 2026.
Board meeting on July 22, 2026, to review Q1 FY27 financial results.
Closure aligns with SEBI insider trading regulations.
Focus on financial results for the quarter ending June 30, 2026.

View BSE Filing

DRREDDY

Pharmaceuticals

DR.REDDY'S LABORATORIES LTD.

Price Impact